Joseph E. Gilliam - Feb 23, 2023 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Signature
Diana Scherer, Attorney-in-Fact
Stock symbol
GKOS
Transactions as of
Feb 23, 2023
Transactions value $
-$8,190,336
Form type
4
Date filed
2/27/2024, 09:29 PM
Previous filing
Jan 13, 2023
Next filing
Mar 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Options Exercise $1.04M +26.7K +22.26% $39.10 146K Feb 23, 2024 Direct F1
transaction GKOS Common Stock Options Exercise $3.1M +74.4K +50.81% $41.69 221K Feb 23, 2024 Direct F1
transaction GKOS Common Stock Options Exercise $406K +13.1K +5.94% $30.92 234K Feb 23, 2024 Direct F1
transaction GKOS Common Stock Options Exercise $180K +4.61K +1.97% $39.10 239K Feb 23, 2024 Direct F1
transaction GKOS Common Stock Sale -$1.95M -21.4K -8.97% $90.94 217K Feb 23, 2024 Direct F1, F2
transaction GKOS Common Stock Sale -$10.6M -115K -52.82% $92.33 102K Feb 23, 2024 Direct F1, F3
transaction GKOS Common Stock Sale -$381K -4.09K -3.99% $93.05 98.4K Feb 23, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Options Exercise $0 -74.4K -62.88% $0.00 43.9K Feb 23, 2024 Common Stock 74.4K $41.69 Direct F5, F6
transaction GKOS Stock Option (Right to Buy) Options Exercise $0 -13.1K -100% $0.00* 0 Feb 23, 2024 Common Stock 13.1K $30.92 Direct F6, F7
transaction GKOS Stock Option (Right to Buy) Options Exercise $0 -26.7K -96.2% $0.00 1.05K Feb 23, 2024 Common Stock 26.7K $39.10 Direct F8, F9
transaction GKOS Stock Option (Right to Buy) Options Exercise $0 -4.61K -100% $0.00* 0 Feb 23, 2024 Common Stock 4.61K $39.10 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $90.37 to $91.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $91.79 to $92.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $92.80 to $93.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
F6 The amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution.
F7 This option was granted on March 14, 2018 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
F8 This option was granted on March 12, 2020 and has a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.
F9 The amount reported reflects an adjustment of 5,000 shares underlying a stock option grant reported as exercised on a Form 4 filed with the Securities and Exchange Commission on February 12, 2024. The exercise was inadvertently attributed to the stock option grant issued on 3/12/2020 and subject to a time-based vesting schedule, but should have been attributed to the stock option grant issued on 3/12/2020 and subject to performance-based vesting requirements. In addition, the amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution.
F10 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
F11 The amount reported reflects an adjustment of 5,000 shares underlying a stock option grant reported as exercised on a Form 4 filed with the Securities and Exchange Commission on February 12, 2024. The exercise was inadvertently attributed to the stock option grant issued on 3/12/2020 and subject to a time-based vesting schedule, but should have been attributed to the stock option grant issued on 3/12/2020 and subject to performance-based vesting requirements.